Hereditary and Chemotherapy-Associated Cardiomyopathies

Donnerstag, 4. April | 09:30 - 11:00 Uhr | Posterbereich 11

Vorsitz/Chair: Jes-Niels Boeckel (Leipzig), Denise Hilfiker-Kleiner (Marburg)


Male human induced pluripotent stem cell-derived cardiomyocytes demonstrate higher cell death upon doxorubicin treatment than female iPSC-derived cardiomyocytes
E. T. Strässler (Berlin)
A potential cardioprotective role of epigenetic repression in long-term cardiotoxicity of anthracyclines
B. Eksi (Heidelberg)
Identification of the cardiomyocyte inflammasome pathway as a crucial signaling pathway in immune checkpoint inhibitor-associated myocarditis
J. Brauer (Heidelberg)
Echocardiographic Shear wave elastography derived myocardial stiffness detects cardiac dysfunction and is linked to reduced cardiorespiratory fitness among childhood cancer survivors post-chemotherapy
A. Youssef (Leuven)
Lemd2 haploinsufficiency results in defects in cardiomyocyte proliferation
R. Chen (Würzburg)
Decreased RNA-degradation underlies allelic imbalance of MYH7 in cardiac tissue of Hypertrophic Cardiomyopathy patients with mutation R723G
J. Montag (Hannover)
PAR2 deficiency reduces the synthesis of amyloidogenic proteins in the mouse model
E. P. Ghanbari (Berlin)
Delineating SLM2's Regulatory Role in Cardiac Stress and Splicing Homeostasis
M. Klop (Heidelberg)
Diese Seite teilen